New York, NY - (ACCESSWIRE) - 11/13/2013 - Growing Stock Report initiates its NASDAQ Active Stock Weekly Watch List adding Breitburn Energy Partners L.P. (NASDAQ:BBEP), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), xG Technology, Inc. (NASDAQ:XGTI) and Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Breitburn Energy Partners L.P. (NASDAQ:BBEP) a company that engages in the acquisition, exploitation, and development of oil and gas properties in the United States is currently down (-4.20%) on 7,516,369 shares traded after BreitBurn Energy Partners L.P. announced today the pricing of its public offering of 16,500,000 common units representing limited partner interests in the Partnership at a price to the public of $18.22 per unit. Breitburn Energy Partners L.P. (NASDAQ:BBEP) is currently down (-16.23%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Breitburn Energy Partners L.P. (NASDAQ:BBEP)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=BBEP&SubId=AW
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products is currently down (-9.31%) on 3,169,892 shares traded after Chelsea Therapeutics International, Ltd. announced today that it has priced an underwritten public offering of 6,666,667 shares of its common stock at an offering price of $3.00 per share, for total gross proceeds of approximately $20 million. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently down (-13.88%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)
Click Here: http://www.growingstockreport.com/Survey.aspx?stock=CHTP&SubId=AW
xG Technology, Inc. (NASDAQ:XGTI) a company that develops communications technologies for wireless networks is currently down (-16.50%) on 393,200 shares traded after xG Technology, Inc. announced Pricing of Public Offering of Common Stock. xG Technology, Inc. (NASDAQ:XGTI) is currently down (-81.89%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about xG Technology, Inc. (NASDAQ:XGTI)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=XGTI&SubId=AW
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) a biopharmaceutical company that focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases is currently down (-11.31%) on 2,626,685 shares traded after Synta Pharmaceuticals Corp. announced today that it has priced an underwritten public offering of 14,000,000 shares of its common stock at a price to the public of $3.75 per share. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is currently down (-68.86%) from its recent 52-week high, which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.
To find out what other Investors are saying about Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Click Here: http://www.growingstockreport.com/Survey.aspx?stock=SNTA&SubId=AW
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.growingstockreport.com/Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:Growing Stock Report
[email protected]